Suchergebnisse - "Audhuy, B."

PubPharm (91)

1

Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype : a FILO study

enthalten in: Leukemia | 2021

von Largeaud, L. | Cornillet-Lefebvre, P. | Hamel, J. | +116

2

Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma

enthalten in: The New England journal of medicine | 2017

von Attal, M. | Lauwers-Cances, V. | Hulin, C. | +109

CommentIn: Nat Rev Clin Oncol. 2017 Aug;14(8):461-462. - PMID 28607521

3

HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12 : impact on susceptibility to first-line strategies

enthalten in: The Journal of antimicrobial chemotherapy | 2015

von Frange, P. | Assoumou, L. | Descamps, D. | +118

4

Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma

enthalten in: The New England journal of medicine | 2014

von Benboubker, L. | Dimopoulos, M. | Dispenzieri, A. | +132

CommentIn: N Engl J Med. 2014 Sep 4;371(10):961-2. - PMID 25184869

5

ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline) : final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2014

von Mounier, N. | Brice, P. | Bologna, S. | +55

6

Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia : long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group

enthalten in: Haematologica | 2014

von Bertoli, S. | Bories, P. | Béné, M. | +63

7

A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil-epirubicine-cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000)

enthalten in: European journal of cancer (Oxford, England : 1990) | 2014

von Delbaldo, C. | Serin, D. | Mousseau, M. | +11

8

A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil–epirubicine–cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000)

enthalten in: The European journal of cancer / A | 2014

von Delbaldo, C. | Serin, D. | Mousseau, M. | +10

9

Optimisation de l’approche globale du patient atteint d’un cancer

enthalten in: Oncologie | 2014

von Audhuy, B.

10

Optimisation de l’approche globale du patient atteint d’un cancer

enthalten in: Oncologie | 2014

von Audhuy, B.

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]